These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 19046313)

  • 1. Warfarin anticoagulation intensity in specialist-based and in computer-assisted dosing practice.
    Onundarson PT; Einarsdottir KA; Gudmundsdottir BR
    Int J Lab Hematol; 2008 Oct; 30(5):382-9. PubMed ID: 19046313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective controlled trial comparing weekly self-testing and self-dosing with the standard management of patients on stable oral anticoagulation.
    Watzke HH; Forberg E; Svolba G; Jimenez-Boj E; Krinninger B
    Thromb Haemost; 2000 May; 83(5):661-5. PubMed ID: 10823258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreasing warfarin sensitivity during the first three months after heart valve surgery: implications for dosing.
    Meijer K; Kim YK; Schulman S
    Thromb Res; 2010 Mar; 125(3):224-9. PubMed ID: 19336266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of subtherapeutic anticoagulation in the United States.
    Rose AJ; Ozonoff A; Grant RW; Henault LE; Hylek EM
    Circ Cardiovasc Qual Outcomes; 2009 Nov; 2(6):591-7. PubMed ID: 20031897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
    Clark NP; Witt DM; Delate T; Trapp M; Garcia D; Ageno W; Hylek EM; Crowther MA;
    Pharmacotherapy; 2008 Aug; 28(8):960-7. PubMed ID: 18657012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.
    Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH
    Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose vitamin K to augment anticoagulation control.
    Reese AM; Farnett LE; Lyons RM; Patel B; Morgan L; Bussey HI
    Pharmacotherapy; 2005 Dec; 25(12):1746-51. PubMed ID: 16305294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Search for predictors of nontherapeutic INR results with warfarin therapy.
    McGriff-Lee NJ; Csako G; Chen JT; Dang DK; Rosenfeld KG; Cannon RO; Macklin LR; Wesley RA;
    Ann Pharmacother; 2005 Dec; 39(12):1996-2002. PubMed ID: 16288081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective and prospective analyses of the treatment of overanticoagulated patients.
    Duong TM; Plowman BK; Morreale AP; Janetzky K
    Pharmacotherapy; 1998; 18(6):1264-70. PubMed ID: 9855325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of patient self-managed versus physician-managed oral anticoagulation.
    Sunderji R; Gin K; Shalansky K; Carter C; Chambers K; Davies C; Schwartz L; Fung A
    Can J Cardiol; 2004 Sep; 20(11):1117-23. PubMed ID: 15457308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicentre randomised clinical endpoint study of PARMA 5 computer-assisted oral anticoagulant dosage.
    Poller L; Keown M; Ibrahim S; Lowe G; Moia M; Turpie AG; Roberts C; van den Besselaar AM; van der Meer FJ; Tripodi A; Palareti G; Jespersen J
    Br J Haematol; 2008 Oct; 143(2):274-83. PubMed ID: 18759767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual time within target range in patients treated with vitamin K antagonists: main determinant of quality of anticoagulation and predictor of clinical outcome. A retrospective study of 2300 consecutive patients with venous thromboembolism.
    Veeger NJ; Piersma-Wichers M; Tijssen JG; Hillege HL; van der Meer J
    Br J Haematol; 2005 Feb; 128(4):513-9. PubMed ID: 15686461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program.
    Poller L; Keown M; Ibrahim S; Lowe G; Moia M; Turpie AG; Roberts C; van den Besselaar AM; van der Meer FJ; Tripodi A; Palareti G; Shiach C; Bryan S; Samama M; Burgess-Wilson M; Heagerty A; Maccallum P; Wright D; Jespersen J;
    Thromb Haemost; 2009 Mar; 101(3):487-94. PubMed ID: 19277410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. International normalized ratio self-management lowers the risk of thromboembolic events after prosthetic heart valve replacement.
    Eitz T; Schenk S; Fritzsche D; Bairaktaris A; Wagner O; Koertke H; Koerfer R
    Ann Thorac Surg; 2008 Mar; 85(3):949-54; discussion 955. PubMed ID: 18291177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Warfarin treatment in a general practice].
    Bratland B
    Tidsskr Nor Laegeforen; 2006 Jan; 126(2):162-5. PubMed ID: 16415938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the optimal level of anticoagulation in adult patients receiving warfarin following implantation of a mechanical prosthetic mitral valve?
    Bayliss A; Faber P; Dunning J; Ronald A
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):390-6. PubMed ID: 17669876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed doses.
    Grzymala-Lubanski B; Själander S; Renlund H; Svensson PJ; Själander A
    Thromb Res; 2013 Feb; 131(2):130-4. PubMed ID: 23232091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hospitalization on oral anticoagulation control: a population-based study.
    van Walraven C; Austin PC; Oake N; Wells P; Mamdani M; Forster AJ
    Thromb Res; 2007; 119(6):705-14. PubMed ID: 16844204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management strategies for optimal control of anticoagulation in patients with atrial fibrillation.
    Levi M; de Peuter OR; Kamphuisen PW
    Semin Thromb Hemost; 2009 Sep; 35(6):560-7. PubMed ID: 19787560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed discharges due to initiation of warfarin in atrial fibrillation: a prospective audit.
    Tan ES; Bonnett TJ; Abdelhafiz AH
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):232-5. PubMed ID: 17996662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.